HANGZHOU ALLTEST BIOTECH CO.,LTD

2024

Top 20 ESG Award in 228 Listing Companies
2023

US FDA OTC approved for FYL Test Turn Over: 300 million tests
2022

US FDA POC approved for Pregnancy Test. Turn Over: 500 million tests
2021

March 25, Successfully listed on the STAR Market of the Shanghai Stock Exchange (SSE)
2020

Capacity reached a record high of 400 million
2019

Jan, MDSAP Approved FOB, Tropnin I, HIV registered in China. April, US FDA CLIA Waived and OTC Cleared for Drug Tests.
2018

Jan, flawlessly passed US FDA audit
2017

May, HCG registered in China. Got ISO13485:2016
2016

Korea GMP/Health Canada Approved. Got the Hi-Tech Enterprise Certificate
2015

Oct. USA FDA facility
2014

CE/ISO/CFDA Approved
2012

Developing Rapid Test
2009

Company Established